The abstract is read at the publisher; the summary is JClub's.
Anti-MPL neutralizing antibody markedly improved cardiac microvascular pathology in chimeric mice with JAK2V617F-mutant blood cells under high-fat/high-cholesterol diet.
- Why it matters: JAK2V617F-mutant myeloproliferative neoplasms and clonal hematopoiesis are linked to cardiovascular disease, but how mutant blood cells drive cardiac microvascular dysfunction is unclear.
- What they did: Chimeric mice received JAK2V617F-mutant bone marrow and wild-type endothelium, then were challenged with a high-fat/high-cholesterol diet; single-cell RNA sequencing and MPL immunostaining focused on endocardial ECs.
- The result: JAK2V617F-mutant hematopoiesis activated inflammatory and stress-response programs and endothelial-to-mesenchymal transition in endocardial ECs, with MPL upregulation, and anti-MPL treatment restored endocardial integrity and increased coronary microvascular density.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.